{
  "docId": "019de514-833c-7520-a4a9-200b68fbb681",
  "docSlug": "d869e39fe11534a9d64784c9e4f475f2",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 47 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 47,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de514-833c-7520-a4a9-200b68fbb681/24",
  "deckHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681",
  "deckJsonHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681.json",
  "deckAnchorHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.21,
        "w": 0.519,
        "x": 0.38,
        "y": 0.659
      },
      "kind": "list",
      "text": "Launched XIPERE® and positive early results\nLaunched Revive™ Custom Soft Contact lenses\nLaunched Project Watson™ healthcare product for dogs\nEntered into an exclusive European distribution agreement for MIMS® minimally invasive surgical procedure for treatment of glaucoma\nEnrolled first patient in LASIK clinical trial for Technolas® TENEO™ Excimer Laser",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "059c9104-9d12-4443-8f08-15ad3b46ad31",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.208,
        "x": 0.08,
        "y": 0.69
      },
      "kind": "list",
      "text": "Expand into new product categories",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3fe45f91-d7e4-4a69-bf3f-6f0a1587dd11",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.208,
        "x": 0.08,
        "y": 0.235
      },
      "kind": "list",
      "text": "Continue momentum in current portfolio",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa71ac64-0ece-4d22-9009-dd46095c6241",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.208,
        "x": 0.08,
        "y": 0.46
      },
      "kind": "list",
      "text": "Invest in categories growing faster than market",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4ddaccb-a64e-44a2-949c-5199908d268d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.16,
        "w": 0.519,
        "x": 0.38,
        "y": 0.43
      },
      "kind": "list",
      "text": "Continued rollout of Daily SiHy\nStrong performance in implantables, following premium IOL rollout\nPlanning for upcoming launch of 3D microscope\nFDA filing acceptance of NOV03 (PDUFA date June 2023)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e8ecfaa4-0fb7-450d-9633-3429b733bd22",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.21,
        "w": 0.519,
        "x": 0.38,
        "y": 0.176
      },
      "kind": "list",
      "text": "4-5% organic revenue growth in FY22 expected 1,2\nStrong performance in key franchises: Ocuvite® + PreserVision®, LUMIFY®, Artelac®, BioTrue® Global Mega Brand and core vision care brands (BioTrue® ONEday, Bausch + Lomb ULTRA®, Daily SiHy)\nGeo-expansion and line extensions in numerous key franchises\nMarket share gains seen across key franchises",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe1938c7-274f-44f9-9576-3bd8e7015d02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.727,
        "x": 0.16,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. This is a non-GAAP measure or ratio. See Slide 2 and Appendix for further information on non-GAAP measures or ratios. See slides 10 and 11 for disclosure of historic non-GAAP measures and ratios and their historic comparable GAAP measures and ratios.\n2. The guidance in this presentation is only effective as of the date given, Nov. 2, 2022, and will not be updated or affirmed unless and until the Company publicly announces updated or affirmed guidance. Distribution or reference of this deck following Nov. 2, 2022 does not constitute the Company re-affirming guidance. See Slide 1 for further information on forward-looking statements.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "04608f71-fef2-44af-867a-e6936c715149",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.018,
        "x": 0.946,
        "y": 0.946
      },
      "kind": "source-note",
      "text": "23",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8735cd2-6fb9-4841-8592-fd12e83867c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.477,
        "x": 0.046,
        "y": 0.08
      },
      "kind": "title",
      "text": "Delivering on Areas of Key Focus in 2022",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7eed333c-1729-4af9-b60d-5bfacea91187",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 25,
      "from": 16,
      "beatId": "3551c60e-c8e3-45ed-affc-e45af107916b",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Visualization",
      "beatSlug": "monroes-sequence-visualization",
      "evidence": "The deck outlines upcoming catalysts, strengthening key consumer franchises, and R&D opportunities.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}